Systemic Lupus Erythematosus and Virus C Infection - Diagnosis, Evolution and Treatment Particularities

1. Hepatitis C virus infection mimicking systemic lupus erythematosus – study of hepatitis C virus infection in a series of 134 spanish patients with systemic lupus erythematosus, Ramos-Casals M. Et al, Arthritis & Rheumatism, vol 43, no 12, 2000; pp 2801-2806.10.1002/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-VSearch in Google Scholar

2. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. Ramos-Casals M et al, Journal of Internal Medicine 2005; 257:549-557.Search in Google Scholar

3. Prevalence of Active Hepatitis C Virus Infection in Patients with systemic lupus erhythematosus, Mubashir et al., American Journal of Science, 2006; 331(5):252-256.Search in Google Scholar

4. Hepatitis C virus antibodies in systemic lupus erythematosus, Kowdley KV et al, J Clin Gastroenterol 1997, Sep 25(2):437-910.1097/00004836-199709000-00008Search in Google Scholar

5. Hepatitis C virus infection in systemic lupus erhytematosus: a case-control study, Perlemuter et al, J Rheumatol 2003; 30;1473-1478.Search in Google Scholar

6. Hepatitis C-associated glomerulonephritis mimicking systemic lupus erythematosus, Krajewska M et al, Scandinavian Journal of Rheumatology,2015, At:22:41.Search in Google Scholar

7. Delayed onset of systemic lupus erythematosus in patients with „full-house” nephropathy, Gianviti A. et al., Pediatr Nephrol. 1999; 13(8):683-7.10.1007/s004670050681Search in Google Scholar

8. Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infection, Hobeika L et al, CEN Case Rep (2012) 1:29-33.10.1007/s13730-012-0008-3Search in Google Scholar

9. Low titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C, Bell T.M. et al, J Gastroenterol Hepatol, 1999; 14(5):419-22.10.1046/j.1440-1746.1999.01896.xSearch in Google Scholar

10. Interferon alpha-induced lupus Proof of Principle, Niewold T. J Clin Rheumatol, 2008; 14(3): 131-132.10.1097/RHU.0b013e318177627dSearch in Google Scholar

11. Hepatitis C virus infection, interferon alfa and lupus; a curious combination, Martinez-Mier G et al, Nefrologia 2014; 34(4):534-6.Search in Google Scholar

12. Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C, Ho V. et al, J Clin Rheumatol 2008;14:166-168.10.1097/RHU.0b013e3181775e80Search in Google Scholar

13. Lupus- like immune complex- mediated glomerulonephritis in patients with hepatitis C virus C infection treated with oral, interferon- free, direct acting antiviral Sise et al, Kidney Int Rep (2016) 1, 135-143.10.1016/j.ekir.2016.06.006Search in Google Scholar

14. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue, Vento et al, Lancet Oncol 2002; 3:333-40.10.1016/S1470-2045(02)00773-8Search in Google Scholar

15. Reactivation of hepatitis C virus and its cllinical outcomes in patients treated with systemic chemotherapy or immunosuppressive therapy, Him Lee et al, Gut and Liver, vol 11, No 6, 2017, pp 870-877.10.5009/gnl16434Search in Google Scholar

16. Hepatitis C virus infection and vasculitis – implication of antiviral and immunosuppressive therapies, Vassilopoulos et al, Arthritis & Rheumatism, vol 46, no 3, 2002, pp 585-59710.1002/art.1010711920393Search in Google Scholar

17. Treatment of hepatitis C in patients undergoing immunosuppressive drug therapy, Ooka K et al, Journal of Clinical and translational hepatology, 2016 vol 4; 206-227.Search in Google Scholar

18. Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy, Chen W-H. et al, Lupus (2015), http://lup.sagepub.com, 2015.Search in Google Scholar

19. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease, Tsui JI et al, Arch Intern Med 167: 1271–1276.10.1001/archinte.167.12.127117592100Search in Google Scholar

20. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease, Iliescu L. Et al, BMC Nephrology (2020) 21:21.10.1186/s12882-020-1687-1696684331948406Search in Google Scholar

21. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome, Mitwalli H et al, Nephrol Dial Transplant (2012) 27:627-632.10.1093/ndt/gfr32721771749Search in Google Scholar